Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ... - Nasdaq

Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ... - Nasdaq | marketing - Google News | August 18, 2015 at 01:32PM

Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ... Nasdaq The settlement resolves allegations that Amgen illegally used a practice called off-label marketing to promote two biologic medications, Arenesp and Enbrel, for purposes that had not been approved by the Food and Drug Administration (FDA) or for which ... and more »

August 18, 2015 at 01:32PM | marketing - Google News
Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ... - Nasdaq
marketing - Google News